See more : Plus Alpha Consulting Co.,Ltd. (4071.T) Income Statement Analysis – Financial Results
Complete financial analysis of Aurora Spine Corporation (ASAPF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Aurora Spine Corporation, a leading company in the Medical – Devices industry within the Healthcare sector.
- Enlight Corporation (2438.TW) Income Statement Analysis – Financial Results
- Lee Pharmaceuticals, Inc. (LPHM) Income Statement Analysis – Financial Results
- TaiGen Biopharmaceuticals Holdings Limited (4157.TWO) Income Statement Analysis – Financial Results
- CBD Life Sciences Inc. (CBDL) Income Statement Analysis – Financial Results
- JE Cleantech Holdings Limited (JCSE) Income Statement Analysis – Financial Results
Aurora Spine Corporation (ASAPF)
About Aurora Spine Corporation
Aurora Spine Corporation, through its subsidiary, Aurora Spine, Inc., engages in the development and distribution of minimally invasive interspinous fusion systems and devices in Canada. The company offers interspinous process lumbar fusion devices, such as the ZIP, ZIP ULTRA, ZIP LP, and ZIP-51 for patients suffering from degenerative disc diseases; and Ti-Coated polyether ether ketone interbody cages, which provide spacing and stability between the vertebrae while bone grows to complete the fusion process. It also provides sterile-packed titanium plasma spray coated spinal infusion implants for bone growth, as well as interbody products, such as EOS, VOX, Echo, Echo SD, and EchoXL for the lumbar section of the spine, and discovery for cervical procedures. In addition, the company provides SOLO, an anterior lumbar interbody fusion 3D printed stand-alone fusion device, which is an integrated plate and spacer system that helps to preserve the natural anatomic profile while providing spinal column support and stability; and SiLo, a posterior fusion device for the sacroiliac joint. Further, it offers DEXA-C, a cervical interbody system, which is a porous 3D-printed intervertebral body fusion device that incorporates low-, mid-, or high-density lattice pattern options to support the matching of patients' bone quality. Aurora Spine Corporation was incorporated in 2013 and is headquartered in Toronto, Canada.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 14.52M | 14.88M | 10.54M | 8.65M | 11.15M | 8.68M | 5.99M | 6.76M | 4.90M | 2.59M | 206.99K |
| Cost of Revenue | 6.31M | 7.07M | 5.71M | 5.18M | 7.61M | 4.09M | 3.43M | 3.37M | 2.21M | 1.14M | 82.80K |
| Gross Profit | 8.21M | 7.81M | 4.83M | 3.47M | 3.55M | 4.59M | 2.56M | 3.38M | 2.69M | 1.45M | 124.19K |
| Gross Profit Ratio | 56.55% | 52.49% | 45.84% | 40.12% | 31.81% | 52.90% | 42.73% | 50.08% | 54.91% | 56.04% | 60.00% |
| Research & Development | 1.11M | 1.16M | 941.30K | 286.25K | 207.55K | 36.30K | 21.06K | 40.41K | 78.12K | 280.69K | 158.19K |
| General & Administrative | 6.82M | 6.08M | 4.99M | 3.65M | 3.89M | 3.64M | 3.70M | 4.11M | 4.71M | 7.30M | 1.14M |
| Selling & Marketing | 722.29K | 1.05M | 799.93K | 106.01K | 138.92K | 47.14K | 31.86K | 91.43K | 287.68K | 1.00M | 140.28K |
| SG&A | 7.54M | 7.12M | 5.79M | 3.76M | 4.03M | 3.68M | 3.74M | 4.20M | 5.00M | 8.30M | 1.28M |
| Other Expenses | 0.00 | 868.59K | 648.69K | 589.54K | 386.65K | 780.56K | 984.11K | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 8.66M | 9.15M | 7.38M | 4.63M | 4.63M | 4.50M | 4.74M | 5.00M | 5.81M | 8.96M | 1.45M |
| Cost & Expenses | 14.97M | 16.22M | 13.10M | 9.81M | 12.23M | 8.59M | 8.17M | 8.37M | 8.02M | 10.10M | 1.45M |
| Interest Income | 0.00 | 0.00 | 0.00 | 4.63K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 185.17K | 163.60K | 157.70K | 92.35K | 174.01K | 147.59K | 144.65K | 60.93K | 26.93K | 0.00 | 0.00 |
| Depreciation & Amortization | 1.05M | 834.17K | 642.98K | 620.68K | 395.64K | 740.76K | 855.88K | 752.84K | 750.81K | 385.82K | 3.80K |
| EBITDA | -446.20K | -450.68K | -1.54M | -686.23K | -709.74K | 816.09K | -1.35M | -869.19K | -2.00M | -7.15M | -3.40M |
| EBITDA Ratio | -3.07% | -2.74% | -18.03% | -6.64% | -6.21% | 10.04% | -22.62% | -12.67% | -52.56% | -274.90% | -696.43% |
| Operating Income | -446.20K | -1.34M | -2.55M | -1.16M | -1.08M | 91.44K | -2.18M | -1.68M | -3.12M | -7.51M | -1.45M |
| Operating Income Ratio | -3.07% | -9.03% | -24.19% | -13.46% | -9.68% | 1.05% | -36.42% | -24.85% | -63.70% | -289.79% | -698.27% |
| Total Other Income/Expenses | -1.23M | -158.06K | 191.04K | 931.31K | -174.79K | -159.64K | -59.30K | 0.00 | 205.32K | 0.00 | 0.00 |
| Income Before Tax | -1.68M | -1.50M | -2.36M | -232.09K | -1.25M | -68.20K | -2.24M | -1.68M | -2.92M | -7.51M | -1.45M |
| Income Before Tax Ratio | -11.57% | -10.09% | -22.37% | -2.68% | -11.25% | -0.79% | -37.41% | -24.85% | -59.51% | -289.79% | -698.27% |
| Income Tax Expense | 0.00 | 62.29K | 159.10K | 87.71K | 174.01K | 12.05K | -85.35K | 60.93K | -205.32K | 0.00 | 0.00 |
| Net Income | -1.68M | -1.56M | -2.52M | -319.80K | -1.43M | -80.25K | -2.16M | -1.68M | -2.92M | -7.51M | -1.45M |
| Net Income Ratio | -11.57% | -10.51% | -23.88% | -3.70% | -12.81% | -0.92% | -35.98% | -24.85% | -59.51% | -289.79% | -698.27% |
| EPS | -0.02 | -0.02 | -0.04 | -0.01 | -0.03 | 0.00 | -0.06 | -0.05 | -0.11 | -0.35 | -0.22 |
| EPS Diluted | -0.02 | -0.02 | -0.04 | -0.01 | -0.03 | 0.00 | -0.06 | -0.05 | -0.11 | -0.35 | -0.22 |
| Weighted Avg Shares Out | 70.67M | 66.80M | 58.71M | 54.63M | 46.46M | 42.15M | 35.18M | 32.22M | 25.95M | 21.62M | 6.58M |
| Weighted Avg Shares Out (Dil) | 70.67M | 66.80M | 58.71M | 54.63M | 46.46M | 42.15M | 35.18M | 32.22M | 25.95M | 21.62M | 6.58M |
Aurora Spine Corporation to Participate in the Lytham Partners Winter 2021 Investor Conference
Aurora Spine Corporation (ASAPF) CEO Trent Northcutt on Q3 2021 Results - Earnings Call Transcript
Aurora Spine Corporation Schedules Release for Third Quarter 2021 Financial Results and Webcast Call
Aurora Spine Corporation to Present at the Lytham Partners Fall 2021 Investor Conference
Aurora Spine Corporation Announces Participation at the North American Spine Society Annual Meeting
Aurora Spine Corporation Announces Closing of C$6.5 Million Private Placement with Institutional Investors
Aurora Spine Corporation Announces C$6.5 Million Private Placement with Institutional Investors
Aurora Spine Corporation Announces Second Quarter 2021 Financial Results
Aurora Spine Corporation Announces First Patients in Multicenter Study of ZIP® Interspinous Fixation Device
Aurora Spine Corporation Announces FDA 510(k) Clearance for DEXA-C™ Cervical Interbody System
Source: https://incomestatements.info
Category: Stock Reports